{"id":"W3006937281","doi":"10.1200/jgo.19.00380","title":"Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts","year":2020,"lang":"en","type":"article","venue":"JCO Global Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; University of Calgary; CancerCare Manitoba; McMaster University; McGill University Health Centre; Juravinski Cancer Centre; BC Cancer Agency; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"Genentech; Eisai; Ipsen; Mirati Therapeutics; U.S. Department of Defense; Exelixis; GlaxoSmithKline; Dana-Farber/Harvard Cancer Center; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Congressionally Directed Medical Research Programs; Astellas Pharma; Gateway for Cancer Research; Pfizer; Karyopharm Therapeutics","keywords":"Renal cell carcinoma; Tyrosine kinase; Medicine; Cancer research; Oncology; Internal medicine; Carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00005066161,0.0004718261,0.001182212,0.00009527789,0.00005864896,0.00002110503,0.000089992,0.0001286198,0.00006848577],"category_scores_gemma":[0.00004376562,0.0002977495,0.00007422893,0.0004970315,0.000180012,0.000114526,0.000103402,0.0002398061,0.00003396504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006774076,"about_ca_system_score_gemma":0.0002442737,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00139338,"about_ca_topic_score_gemma":0.005237348,"domain_scores_codex":[0.9977139,0.0001548721,0.0005249198,0.000729741,0.0004077355,0.0004688851],"domain_scores_gemma":[0.9986421,0.000129187,0.0002437398,0.0003121873,0.0001652465,0.0005074921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004376498,0.001501539,0.988151,0.00008274646,0.0001965347,0.004264165,0.0005949635,0.00009098642,0.0001143269,0.00001223008,0.0003508691,0.0002641245],"study_design_scores_gemma":[0.03352866,0.01145813,0.9513319,0.00008964947,0.0007724804,0.00002569645,0.0001344736,0.0002654108,0.001169553,0.00002159926,0.0009108861,0.000291585],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949146,0.000400074,0.00003030565,0.001692291,0.00004767826,0.001292731,0.0002575086,0.00005674086,0.001308105],"genre_scores_gemma":[0.9967316,0.00001774768,0.001307001,0.001151484,0.00009282232,0.00004583226,0.0005604903,0.00003821038,0.00005483808],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03681914,"threshold_uncertainty_score":0.9999475,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01456501652986863,"score_gpt":0.2531003604163637,"score_spread":0.2385353438864951,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}